文献速递脑血管病

卵圆孔未闭与肺动静脉畸形患者的复发性卒中风险:全国性研究

Risk of Recurrent Stroke Among Patients With Patent Foramen Ovale vs Pulmonary Arteriovenous Malformation: A Nationwide Study.
PubMed 文献 · Neurology · 2025-09-25

本研究基于2016-2022年全国再入院数据库,回顾性分析隐源性卒中(CS)患者,比较合并肺动静脉畸形(pAVM)与卵圆孔未闭(PFO)者的复发性卒中风险。共纳入65,611例PFO患者和471例pAVM患者,多变量调整后,pAVM患者300天复发性卒中风险为5.3%,PFO患者为2.9%,两者无显著差异(HR 1.46 [95% CI 0.45-4.67], p=0.53)。结论认为,在评估复发性卒中风险时,pAVM可合理视为等同于PFO。

要点

  • pAVM患者300天复发性卒中风险为5.3%,PFO患者为2.9%。
  • 多变量调整后,两组复发性卒中风险无显著差异(HR 1.46, 95% CI 0.45-4.67, p=0.53)。
  • 在隐源性卒中患者中,pAVM可合理视为与PFO等效的复发性卒中风险因素。

核心结论

  • 在隐源性卒中患者中,pAVM的存在可合理视为与PFO等效,用于评估复发性卒中风险。

研究设计与样本

  • 回顾性分析2016-2022年全国再入院数据库,纳入急性缺血性卒中患者,排除栓塞性、血栓性、腔隙性或其他明确病因以识别隐源性卒中。
  • 共纳入65,611例合并PFO的隐源性卒中患者和471例合并pAVM的隐源性卒中患者。
  • 采用Cox回归模型比较多组复发性卒中风险,并对人口学特征、卒中严重程度和卒中危险因素进行多变量调整。

主要发现

  • 至300天时,pAVM患者复发性卒中风险为5.3%,PFO患者为2.9%。
  • 多变量调整后,两组复发性卒中风险无显著差异(HR 1.46 [95% CI 0.45-4.67], p=0.53)。

临床怎么用

  • 在隐源性卒中患者中,发现pAVM时,可参照PFO的风险评估思路来考虑复发性卒中风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Pulmonary arteriovenous malformation (pAVM) is an anatomical intrapulmonary left-to-right vascular shunt, and it may be a cause of paradoxical stroke. However, the risk of stroke associated with pAVMs is unknown. In this study, we seek to quantify the risk of stroke recurrence among cryptogenic stroke (CS) patients with pAVM compared with those with patent foramen ovale (PFO). METHODS: This was a retrospective analysis of the 2016-2022 Nationwide Readmissions Database. Patients with acute ischemic stroke were identified, and those with embolic, thrombotic, lacunar, or other specified stroke etiologies were excluded to identify patients with CS. Recurrent stroke risk was compared between CS patients with PFO and pAVM using Cox regression models with multivariable adjustments for demographics, stroke severity, and stroke risk factors. RESULTS: A total of 65,611 CS patients with PFO and 471 with pAVM were included. By 300 days, patients with pAVM had a 5.3% risk of recurrent stroke, which was not significantly different from 2.9% among patients with PFO after multivariable adjustments (HR 1.46 [95% CI 0.45-4.67], p = 0.53). DISCUSSION: Among patients with CS, the presence of a pAVM may be reasonably considered equivalent to a PFO when estimating the risk of stroke recurrence.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Chen H, McIntyre M, Gandhi D, et al. Risk of Recurrent Stroke Among Patients With Patent Foramen Ovale vs Pulmonary Arteriovenous Malformation: A Nationwide Study. Neurology. 2025. PMID: 40997287. doi:10.1212/WNL.0000000000214186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。